Serum phosphate predicts early mortality in adults starting antiretroviral therapy in lusaka, zambia: A prospective cohort study

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Heimburger, Douglas C ^a,b,d   Koethe, John R ^a,b   Nyirenda, Christopher ^a,c   Bosire, Claire ^d   Chiasera, Janelle M ^d   Blevins, Meridith ^b   Munoz, Andres Julian ^d,e   Shepherd, Bryan E ^b   Potter, Dara ^a   Zulu, Isaac ^a,c   Chisembele Taylor, Angela ^a   Chi, Benjamin H ^a,d   Stringer, Jeffrey S A ^a,d   Kabagambe, Edmond K ^d  

^a CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA   (Zambia)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; C REACTIVE PROTEIN; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS NEVIRAPINE; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE; FERRITIN; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE; PHOSPHATE; STAVUDINE; TENOFOVIR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; METABOLIC PARAMETERS; MORTALITY; OBSERVATIONAL STUDY; PHOSPHATE BLOOD LEVEL; PREDICTION; PROSPECTIVE STUDY; ZAMBIA;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHOSPHATES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; ZAMBIA;

EID: 77956291070     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010687     Document Type: Article

References (31)

1. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
2. UNAIDS (2008. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp) Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS. Accessed April 8, 2010.
3. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. (2006) Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296: 782-793.
4. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R (2005) Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19: 2141-2148.
5. Jerene D, Endale A, Hailu Y, Lindtjorn B (2006) Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis 6: 136.
6. Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, et al. (2008) Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 8: 52.
7. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, et al. (2006) Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 20: 2355-2360.
8. Centers for Disease Control and Prevention (1987) Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 36 Suppl 1: 1S-15S.
9. Kotler DP, Tierney AR, Wang J, Pierson RN, Jr. (1989) Magnitude of body-cellmass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50: 444-447.
10. Heimburger D, Ard J, eds (2006) Handbook of Clinical Nutrition. Philadelphia: Mosby Elsevier.
11. Knochel JP (1977) The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch Intern Med 137: 203-220.
12. Kohn MR, Golden NH, Shenker IR (1998) Cardiac arrest and delirium: presentations of the refeeding syndrome in severely malnourished adolescents with anorexia nervosa. J Adolesc Health 22: 239-243.
13. Boateng AA, Sriram K, Meguid MM, Crook MA (2010) Refeeding syndrome: Treatment considerations based on collective analysis of literature case reports. Nutrition 26: 156-167.
14. Au JT, Kayitenkore K, Shutes E, Karita E, Peters PJ, et al. (2006) Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS 20: 2116-2118
15. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, et al. (2007) Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care 19: 658-665.
16. Muranga FI, Sampath H, Marlett JA, Ntambi JM (2007) Impact of processing technique on the apparent bioavailability of cooking banana (matooke) starch. African Journal of Biochemistry Research 1: 72-77.
17. United States Agency for International Development Food Commodity Fact Sheets, Updated January 2006. Available at http://www.usaid.gov/our_work/humanitarian_assistance/ffp/crg/sec2.htm. Accessed April 8, 2010.
18. Central Statistical Office Zambia (2002) Preliminary Report - Census 2000. Central Statistical Office, Lusaka, Zambia.
19. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, et al. (2007) Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA 298: 1888-1899.
20. Chi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, et al. (2009) Early Clinical and Programmatic Outcomes with Tenofovir-Based Antiretroviral Therapy in Zambia. J Acquir Immune Defic Syndr, Epub ahead of print Dec. pp 2009.
21. Nyirenda DB, Musukwa M, Mugode RH, Shindano J (2005) Revised food composition table of Zambia. Zambia Ministry of Health.
22. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, et al. (2008) Community-based follow-up for late patients enrolled in a district-wide programme for antiretroviral therapy in Lusaka, Zambia. AIDS Care 20: 311-317.
23. Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, et al. (2008) Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retroviruses 24: 555-560.
24. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22: 1897-1908.
25. Little RJA, Rubin DB (1987) Statistical Analysis with Missing Data. New York: Wiley.
26. Brozek J, Chapman CB, Keys A (1948) Drastic food restriction; effect on cardiovascular dynamics in normotensive and hypertensive conditions. J Am Med Assoc 137: 1569-1574.
27. Schnitker MA, Mattman PE, Bliss TL (1951) A clinical study of malnutrition in Japanese prisoners of war. Ann Intern Med 35: 69-96.
28. Nyirenda CZI, Kabagambe EK, Bagchi S, Potter D, Bosire C, Krishnasami Z, Heimburger DC (2009) Acute hypophosphatemia and hypokalemia in a patient starting antiretroviral therapy in Zambia - a new context for refeeding syndrome? A case report. BMJ Case Reports, 3 April 2009.
29. Rosen S, Fox MP, Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4: e298.
30. Koethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, et al. (2010) Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr 53: 507-513.
31. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, et al. (2008) Harrison's Principles of Internal Medicine (17th ed). New York: McGraw-Hill Medical